Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cleavage stimulation factor subunit 1 (CSTF1) is one of the three main subunits of the cleavage stimulation factor (CSTF) complex, which is essential for the 3'-end processing of pre-mRNA—a critical step in mRNA maturation and stability[1][2][3][5][8]. CSTF1 contains transducin-like repeats and is thought to mediate interactions within CSTF, enabling its assembly on the pre-mRNA substrate[2][3][8]. Through its function in mRNA cleavage and polyadenylation, CSTF1 helps regulate gene expression at the post-transcriptional level, impacting overall mRNA stability, export, and translation[1][2][3][6]. While CSTF1 itself is not a direct therapeutic target, disruptions in its activity may contribute to disease, notably cancer and neurological disorders, due to perturbed mRNA processing and altered gene regulation[1]. It is commonly referenced by the abbreviations CSTF1 and CstF-50[2][3][1][8].
No established drugs; thus, no applicable mechanism of action targeting CSTF1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cleavage stimulation factor subunit 1 (CSTF1).